13
|
124
|
8zc5E |
Sars-cov-2 omicron ba.4 spike trimer (6p) in complex with d1f6 fab, focused refinement of rbd region |
16
|
109
|
8zc5C |
Sars-cov-2 omicron ba.4 spike trimer (6p) in complex with d1f6 fab, focused refinement of rbd region |
27
|
220
|
8zc1C |
Sars-cov-2 omicron ba.2 spike trimer (6p) in complex with d1f6 fab, focused refinement of rbd region |
22
|
196
|
8zc5A |
Sars-cov-2 omicron ba.4 spike trimer (6p) in complex with d1f6 fab, focused refinement of rbd region |
12
|
175
|
8zc1B |
Sars-cov-2 omicron ba.2 spike trimer (6p) in complex with d1f6 fab, focused refinement of rbd region |
20
|
228
|
8zc1E |
Sars-cov-2 omicron ba.2 spike trimer (6p) in complex with d1f6 fab, focused refinement of rbd region |
46
|
221
|
8qrgH |
Sars-cov-2 delta rbd complexed with xbb-2 fab and nbc1 |
36
|
219
|
8qrfA |
Sars-cov-2 delta rbd complexed with xbb-6 and beta-49 fabs |
41
|
198
|
8qrfE |
Sars-cov-2 delta rbd complexed with xbb-6 and beta-49 fabs |
52
|
214
|
8qrgL |
Sars-cov-2 delta rbd complexed with xbb-2 fab and nbc1 |
44
|
212
|
8qrfL |
Sars-cov-2 delta rbd complexed with xbb-6 and beta-49 fabs |
44
|
216
|
8qrfB |
Sars-cov-2 delta rbd complexed with xbb-6 and beta-49 fabs |
41
|
226
|
8qrfH |
Sars-cov-2 delta rbd complexed with xbb-6 and beta-49 fabs |
27
|
124
|
8qrgA |
Sars-cov-2 delta rbd complexed with xbb-2 fab and nbc1 |
39
|
186
|
8qrgE |
Sars-cov-2 delta rbd complexed with xbb-2 fab and nbc1 |
28
|
120
|
8tzuC |
Oc43 s1b domain in complex with wnb 293 and wnb 317 |
27
|
127
|
8tzuD |
Oc43 s1b domain in complex with wnb 293 and wnb 317 |
52
|
266
|
8tzuA |
Oc43 s1b domain in complex with wnb 293 and wnb 317 |
31
|
197
|
8f2xA |
Crystal structure of antibody wrair-2123 in complex with sars-cov-2 receptor binding domain |
31
|
197
|
8f2xA |
Crystal structure of antibody wrair-2123 in complex with sars-cov-2 receptor binding domain |
30
|
228
|
8f2xH |
Crystal structure of antibody wrair-2123 in complex with sars-cov-2 receptor binding domain |
30
|
228
|
8f2xH |
Crystal structure of antibody wrair-2123 in complex with sars-cov-2 receptor binding domain |
35
|
210
|
8f2xL |
Crystal structure of antibody wrair-2123 in complex with sars-cov-2 receptor binding domain |
35
|
210
|
8f2xL |
Crystal structure of antibody wrair-2123 in complex with sars-cov-2 receptor binding domain |
34
|
228
|
8sitH |
Crystal structure of sars-cov-2 spike receptor-binding domain in complex with broadly neutralizing antibody cc84.24 fab |
30
|
212
|
8siqL |
Crystal structure of sars-cov-2 spike receptor-binding domain in complex with broadly neutralizing antibodies cc25.36 and cv38-142 fab |
36
|
195
|
8sitA |
Crystal structure of sars-cov-2 spike receptor-binding domain in complex with broadly neutralizing antibody cc84.24 fab |
47
|
194
|
8sdfA |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody cc25.4 |
38
|
226
|
8siqM |
Crystal structure of sars-cov-2 spike receptor-binding domain in complex with broadly neutralizing antibodies cc25.36 and cv38-142 fab |
32
|
229
|
8sisH |
Crystal structure of sars-cov-2 spike receptor-binding domain in complex with broadly neutralizing antibody cc84.2 fab |
40
|
211
|
8sirL |
Crystal structure of sars-cov-2 spike receptor-binding domain in complex with broadly neutralizing antibody cc25.54 fab |
45
|
214
|
8sdfC |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody cc25.4 |
42
|
227
|
8sdfB |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody cc25.4 |
46
|
216
|
8siqN |
Crystal structure of sars-cov-2 spike receptor-binding domain in complex with broadly neutralizing antibodies cc25.36 and cv38-142 fab |
35
|
208
|
8sisL |
Crystal structure of sars-cov-2 spike receptor-binding domain in complex with broadly neutralizing antibody cc84.2 fab |
38
|
227
|
8siqH |
Crystal structure of sars-cov-2 spike receptor-binding domain in complex with broadly neutralizing antibodies cc25.36 and cv38-142 fab |
29
|
195
|
8sisA |
Crystal structure of sars-cov-2 spike receptor-binding domain in complex with broadly neutralizing antibody cc84.2 fab |
28
|
241
|
8sirH |
Crystal structure of sars-cov-2 spike receptor-binding domain in complex with broadly neutralizing antibody cc25.54 fab |
38
|
210
|
8sitL |
Crystal structure of sars-cov-2 spike receptor-binding domain in complex with broadly neutralizing antibody cc84.24 fab |
34
|
195
|
8sirA |
Crystal structure of sars-cov-2 spike receptor-binding domain in complex with broadly neutralizing antibody cc25.54 fab |
37
|
196
|
8siqA |
Crystal structure of sars-cov-2 spike receptor-binding domain in complex with broadly neutralizing antibodies cc25.36 and cv38-142 fab |
47
|
207
|
8ieeA |
Crystal structure of nanobody vhh-31 with mers-cov rbd |
31
|
131
|
8ieeC |
Crystal structure of nanobody vhh-31 with mers-cov rbd |
31
|
128
|
8idoC |
Crystal structure of nanobody vhh-t148 with mers-cov rbd |
55
|
208
|
8idoA |
Crystal structure of nanobody vhh-t148 with mers-cov rbd |
35
|
201
|
8vkpA |
Cryo-em structure of sars-cov-2 xbb.1.5 spike protein in complex with human ace2 (focused refinement of rbd and ace2) |
35
|
201
|
8vknA |
Cryo-em structure of sars-cov-2 xbb.1.5 spike protein in complex with mouse ace2 (focused refinement of rbd and mouse ace2) |
184
|
595
|
8vkpD |
Cryo-em structure of sars-cov-2 xbb.1.5 spike protein in complex with human ace2 (focused refinement of rbd and ace2) |
198
|
593
|
8vknD |
Cryo-em structure of sars-cov-2 xbb.1.5 spike protein in complex with mouse ace2 (focused refinement of rbd and mouse ace2) |
39
|
221
|
8cbdE |
Sars-cov-2 delta-rbd complexed with ba.4/5-1 and ey6a fabs |